4//SEC Filing
Germano Geno J 4
Accession 0001562180-25-004794
CIK 0001597553other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:14 PM ET
Size
7.6 KB
Accession
0001562180-25-004794
Insider Transaction Report
Form 4
Germano Geno J
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-11+21,500→ 21,500 totalExercise: $6.77Exp: 2035-06-11→ Common Stock (21,500 underlying)
Footnotes (1)
- [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan in accordance with Sage's Non-Employee Director Compensation Program. The option will vest in full upon the earlier to occur of June 11, 2026 or the day immediately prior to the 2026 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001424383
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:14 PM ET
- Size
- 7.6 KB